MediSys

VZV

Latest News About - VZV

Filter by countryfromabout

<<10<12345678910>>>10

<<10<12345678910>>>10

Language Selection

For any category/filter, users can choose:

the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

country mentioned in the news item (articles about a country)
country in which the news item was published (articles from a country)

Languages

Select your languages

ar

az

be

bg

bs

ca

cs

da

de

el

en

eo

es

et

fa

fi

fr

ga

gl

ha

he

hi

hr

hu

hy

id

is

it

ja

ka

km

ko

ku

ky

lb

lo

lt

lv

mk

ml

mn

ms

mt

nl

no

pap

pl

ps

pt

ro

ru

se

si

sk

sl

sq

sr

sv

sw

ta

th

tr

uk

ur

vi

zh

all

Show additional languagesHide additional languages

Interface:

Most reported countries (24h)

Theme countries

AlertLevel (24h)

Alert level graph

Previous 14 days average

Alert level:
high medium low

Quotes... Extracted quotes

Mark Genovese said: "Many people with RA struggle with uncontrolled symptoms that affect their daily lives. We are working to develop effective and well-tolerated treatment options that will make a difference in the lives of patients,"

benzinga Thursday, June 4, 2020 7:30:00 AM CEST

Walid Abi said: "After more than 4,544 patient years' exposure thus far, the FINCH and DARWIN programs continue to show that filgotinib has a consistent efficacy and safety profile and has the potential to help more people living with RA achieve symptom control,"

benzinga Thursday, June 4, 2020 7:30:00 AM CEST

Mark Genovese said: “Many people with RA struggle with uncontrolled symptoms that affect their daily lives. We are working to develop effective and well-tolerated treatment options that will make a difference in the lives of patients,”

4-traders Thursday, June 4, 2020 7:10:00 AM CEST

Walid Abi said: “After more than 4,544 patient years’ exposure thus far, the FINCH and DARWIN programs continue to show that filgotinib has a consistent efficacy and safety profile and has the potential to help more people living with RA achieve symptom control,”

4-traders Thursday, June 4, 2020 7:10:00 AM CEST

Kevin Winthrop said: "The results from Lilly's integrated safety analysis help to further characterize the long-term safety of Olumiant as a treatment option in patients with RA,"

4-traders Wednesday, June 3, 2020 12:55:00 PM CEST

Virginia Wotring expliqué: "Les astronautes peuvent alors ressentir des nausées et des étourdissements et avoir des maux de tête. Nous pouvons traiter les symptômes ou simplement donner aux gens des tâches légères pendant quelques jours le temps qu'ils s'adaptent naturellement à leur nouvel environnement"

businessinsider-fr Wednesday, May 27, 2020 2:11:00 PM CEST

Virginia Wotring souligné: "Après des années de recherche, la NASA et d'autres agences spatiales ont découvert qu'une bonne alimentation et de l'exercice physique peuvent prévenir ces deux problèmes. Au moins pour les missions en orbite basse terrestre d'une durée maximale de six mois"

businessinsider-fr Wednesday, May 27, 2020 2:11:00 PM CEST

Virginia Wotring indiqué: "On sait que les effets des radiations spatiales seront plus importants lorsque les missions quitteront l'orbite terrestre basse pour explorer des endroits comme la Lune ou Mars, car la Terre offre une certaine protection contre les radiations spatiales"

businessinsider-fr Wednesday, May 27, 2020 2:11:00 PM CEST

Most associated names

Securities and Exchange Commission

GlaxoSmithKline

European Commission

Centers for Disease Control and Prevention

World Health Organization

Daily number of articles in this category

Trend data not available for this selection.

Most active sources for this category

seatrade-global

noordhollandsdagblad

finanznachrichten-en

Joint Research Centre, Home Affairs, Health and Consumers

ECDC

EFSA